Gus Khursigara
Plus aucun poste en cours
Historique de carrière de Gus Khursigara
Anciens postes connus de Gus Khursigara
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Biohaven Pharmaceuticals, Inc.
 Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Directeur Technique/Scientifique/R&D | 01/07/2018 | 01/09/2019 |
| ALEXION PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - | - |
| INOZYME PHARMA, INC. | Corporate Officer/Principal | 01/11/2019 | - |
Formation de Gus Khursigara
| Cornell University | Doctorate Degree |
| University of Connecticut | Graduate Degree |
| University of California San Diego | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INOZYME PHARMA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Biohaven Pharmaceuticals, Inc.
Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Commercial Services |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- Gus Khursigara
- Expérience
